PubMed دسترسی آزاد

Ten-year outcomes of endothelial keratoplasty versus penetrating keratoplasty in Hong Kong: a retrospective cohort study.

استودیوی صوتی مقاله

پخش حرفه‌ای فارسی و انگلیسی

در حال بررسی نسخه‌های صوتی ذخیره‌شده…

صوت تولیدشده با هوش مصنوعی است. برای کاربرد علمی یا درمانی، متن و منبع اصلی را بررسی کنید.
خواندن هوشمند فارسی و انگلیسی در حال آماده‌سازی صداهای مرورگر…
تنظیم صدای طبیعی و سرعت

صداهایی که در نامشان «Natural»، «Neural» یا «Online» دیده می‌شود معمولاً طبیعی‌ترند. انتخاب صدا به صداهای نصب‌شده در ویندوز و مرورگر شما بستگی دارد.

چکیده اصلی

BACKGROUND: This study compares the long-term survival of primary endothelial (DSEK/DSAEK) versus penetrating keratoplasty in Hong Kong patients with Fuchs endothelial dystrophy (FED) or pseudophakic bullous keratopathy (PBK). METHODS: A ten-year retrospective cohort of patients who received primary Descemet stripping (automated) endothelial keratoplasty (DSEK/DSAEK) or penetrating keratoplasty (PKP) for either FED or PBK at an academic ophthalmology department in Hong Kong between 2006 and 2015 was conducted. RESULTS: Seventy-four eyes of 65 patients received primary keratoplasties with 95 months of mean follow-up, comprising 41 DSEK/DSAEK and 33 PKP. Overall graft survival rates were 76.1% at 5 years and 55.0% at 10 years. DSEK/DSAEK demonstrated higher survival rates than PKP, with 82.1% versus 68.8% survival at 5 years (P = 0.31) and 63.8% versus 43.5% at 10 years (P = 0.15). Older age was associated with graft failure risk. DSEK/DSAEK eyes had better observed best-corrected visual acuity (BCVA) at 5 years (P = 0.006), although this difference was attenuated after adjustment for preoperative BCVA, and the visual difference was no longer apparent at 10 years (P = 0.42). Graft ulcers occurred in fewer eyes receiving DSEK/DSAEK (4.9%) compared to PKP (21.2%) at 10 years (P = 0.033). The cumulative rejection rates were 12.2% for DSEK/DSAEK and 9.1% for PKP at 10 years (P = 0.67) while 14.6% of DSEK/DSAEK and 12.1% of PKP required a re-graft (P = 0.75). CONCLUSIONS: Both primary DSEK/DSAEK and PKP provided meaningful long-term graft survival in this Hong Kong cohort of patients with FED or PBK. DSEK/DSAEK eyes had better observed BCVA at 5 years, although this association was attenuated after adjustment for preoperative BCVA, and the visual difference was no longer apparent at 10 years. DSEK/DSAEK was associated with fewer graft ulcers, while rejection and re-graft rates were similar between groups. These findings should be interpreted in the context of the retrospective design, baseline differences between treatment groups, small subgroup sample sizes, and the historical DSEK/DSAEK techniques represented in this cohort.

متن کامل اصلی

نسخه دارای مجوز در منبع علمی در دسترس است.

لینک مستقیم از metadata منبع گرفته شده و در تب جدید باز می‌شود.

باز کردن متن کامل

کلیدواژه‌ها

Endothelial keratoplastyFuchs endothelial dystrophyKeratoplastyPenetrating keratoplastyPseudophakic bullous keratopathy.
در همین زیرشاخه

مقاله‌های مرتبط

PubMed2026

ATI-2341 TFA promotes acquisition of epithelial-like immunophenotype in bone marrow mesenchymal stem cells and alleviates intrauterine adhesion in a rat model.

BACKGROUND: Intrauterine adhesion (IUA) is a common complication of endometrial injury. Bone marrow mesenchymal stem cells (BMSCs) have been implicated in endometrial repair, but strategies to enhance their therapeutic efficacy remain to be optimized. The C-X-C chemokine receptor type 4 (CXCR4)/C-X-C motif chemokine ligand 12 (CXCL12) axis plays a pivotal role in BMSC homing. OBJECTIVE: This study aimed to test the hypothesis that ATI-…

PubMed2026

Corrigendum to: Bone marrow mesenchymal stem cells relieve rheumatoid arthritis by blocking JAK/STAT and TLR-4/NF-?B pathways.

The authors have informed the Pakistan Journal of Pharmaceutical Sciences (PJPS) of an error in Figure 5 of the published article. During the editorial revision process, an incorrect version of Figure 5 was inadvertently included in the final published version. The authors have confirmed that the extreme-right panel (panel D) should be removed and that the remaining panels constitute the corrected Figure 5. Accordingly, Figure 5 is cor…

PubMed2026

Better to Be Lucky Than Good: How Clinicians and Patients Frame Medical Outcomes.

Notions of good or bad luck sit uncomfortably in contemporary medical practice defined by efforts to control life through biomedical knowledge and skilled expertise. Yet, talk about luck is common in healthcare to explain medical courses of action. Framing medical results as fortunate or unfortunate bridges the gap between predicted probabilities and variation in individual cases without undermining scientific neutrality. Luck mediates…

PubMed2026

Bone marrow mesenchymal stem cells relieve rheumatoid arthritis by blocking JAK/STAT and TLR-4/NF-κB pathways.

BACKGROUND: Rheumatoid arthritis (RA) is a chronic autoimmune disorder characterized by synovial inflammation and joint destruction. Bone marrow mesenchymal stem cells (BMSCs) have shown therapeutic potential in RA, but the underlying mechanisms remain poorly understood. OBJECTIVES: To investigate the effects of BMSCs on human RA fibroblast-like synovial MH7A cells and complete Freund's adjuvant (CFA)-induced arthritis in rats and to e…